Equities researchers at First Analysis assumed coverage on shares of Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) in a research report issued on Wednesday. The brokerage set an “overweight” rating and a $41.00 price target on the stock. First Analysis’ price objective indicates a potential upside of 41.97% from the stock’s previous close.

Several other analysts have also commented on the stock. Piper Jaffray Companies reissued a “buy” rating and set a $29.00 target price on shares of Tabula Rasa Healthcare in a research note on Tuesday, October 24th. Wells Fargo & Company increased their target price on shares of Tabula Rasa Healthcare from $21.00 to $27.00 and gave the company a “market perform” rating in a research note on Thursday, October 19th. Robert W. Baird reissued an “outperform” rating and set a $30.00 target price (up from $22.00) on shares of Tabula Rasa Healthcare in a research note on Tuesday, October 17th. Zacks Investment Research raised shares of Tabula Rasa Healthcare from a “hold” rating to a “strong-buy” rating and set a $31.00 target price for the company in a research note on Wednesday, October 11th. Finally, ValuEngine raised shares of Tabula Rasa Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, September 30th. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Tabula Rasa Healthcare presently has a consensus rating of “Buy” and an average price target of $27.50.

Tabula Rasa Healthcare (NASDAQ:TRHC) last issued its quarterly earnings results on Monday, August 7th. The company reported $0.06 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.06. Tabula Rasa Healthcare had a negative net margin of 10.27% and a negative return on equity of 9.58%. The company had revenue of $29.70 million during the quarter, compared to analyst estimates of $27.84 million. Tabula Rasa Healthcare’s quarterly revenue was up 32.6% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: “Tabula Rasa Healthcare Inc. (TRHC) Coverage Initiated by Analysts at First Analysis” was published by American Banking News and is the property of of American Banking News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/11/01/first-analysis-initiates-coverage-on-tabula-rasa-healthcare-inc-trhc.html.

In other news, insider Orsula V. Knowlton sold 8,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $22.10, for a total transaction of $176,800.00. Following the sale, the insider now owns 887,407 shares in the company, valued at $19,611,694.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 24,000 shares of company stock worth $527,920 in the last 90 days. 45.80% of the stock is owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in TRHC. Paradigm Capital Management Inc. NY acquired a new stake in shares of Tabula Rasa Healthcare during the second quarter valued at approximately $1,165,000. Hood River Capital Management LLC increased its stake in Tabula Rasa Healthcare by 7.5% in the 2nd quarter. Hood River Capital Management LLC now owns 825,225 shares of the company’s stock valued at $12,420,000 after buying an additional 57,724 shares during the period. Northern Trust Corp increased its stake in Tabula Rasa Healthcare by 97.4% in the 2nd quarter. Northern Trust Corp now owns 95,862 shares of the company’s stock valued at $1,443,000 after buying an additional 47,306 shares during the period. Icon Advisers Inc. Co. acquired a new position in Tabula Rasa Healthcare in the 2nd quarter valued at approximately $684,000. Finally, Russell Investments Group Ltd. increased its stake in Tabula Rasa Healthcare by 58.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 94,089 shares of the company’s stock valued at $1,415,000 after buying an additional 34,565 shares during the period. Institutional investors and hedge funds own 27.94% of the company’s stock.

About Tabula Rasa Healthcare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Analyst Recommendations for Tabula Rasa Healthcare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.